Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) EPS (Weighted Average and Diluted) (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with $1.28 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 18.47% year-over-year to $1.28, compared with a TTM value of $4.55 through Dec 2025, up 5.08%, and an annual FY2025 reading of $4.55, up 4.84% over the prior year.
  • EPS (Weighted Average and Diluted) was $1.28 for Q4 2025 at GE HealthCare Technologies, up from $0.98 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.57 in Q4 2024 and bottomed at $0.41 in Q1 2023.
  • Average EPS (Weighted Average and Diluted) over 4 years is $1.01, with a median of $1.0 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 52.33% in 2023, then soared 97.56% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $1.22 in 2022, then dropped by 28.69% to $0.87 in 2023, then surged by 80.46% to $1.57 in 2024, then dropped by 18.47% to $1.28 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GEHC at $1.28 in Q4 2025, $0.98 in Q3 2025, and $1.06 in Q2 2025.